Panacea Biotec secures Rs 127.20 crore government bOPV supply order

Government or defence orderBusiness Updates View source PDF Explain this filing

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.2%Reaction day

₹429.35

prior close

₹432.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+2.0% vs market

Pharmaceuticals peers, median of 153sector+0.5%+1.8% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.5

15m

-0.1

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.2+0.2+2.0+0.5+1.8

Next day

+1.2+0.9+0.3+0.6+0.6

+2.5+0.4+2.1+0.3+2.2

+3.2-0.8+4.0-0.7+3.9

+5.1+0.2+4.9-0.7+5.8

+4.8+0.7+4.1-0.2+5.1

+1.3+1.2+0.1+0.2+1.1

15d

+2.0+2.0+0.0-0.2+2.2

-5.6+0.6-6.2-2.3-3.3

-21.9-4.2-17.7-5.0-16.8

-6.4-6.1-0.3-6.3-0.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Health Ministry's Central Medical Services Society accepted Panacea Biotec's offer to supply bivalent oral polio vaccine. The domestic order is worth Rs 127.20 crore and will be delivered in tranches from 90 to 480 days from October 8, 2025.

Likely market impact

The order supports future sales and earnings, but the benefit depends on delivery timing, costs and margins.